Agios Pharmaceuticals
AGIO
#5052
Rank
C$2.23 B
Marketcap
C$38.31
Share price
1.13%
Change (1 day)
-56.07%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -C$0.67 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are C$44.79 Million. In 2024 the company made an earning of -C$0.59 Billion a decrease over its 2023 earnings that were of -C$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.67 Billion13.65%
2024 -C$0.59 Billion8.75%
2023 -C$0.55 Billion0.63%
2022 -C$0.54 Billion2.81%
2021 -C$0.53 Billion10.58%
2020 -C$0.48 Billion-18.41%
2019 -C$0.58 Billion15.72%
2018 -C$0.51 Billion12.99%
2017 -C$0.45 Billion59.61%
2016 -C$0.28 Billion69.32%
2015 -C$0.17 Billion119.28%
2014 -C$74.79 Million39.22%
2013 -C$53.72 Million69.1%
2012 -C$31.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-C$0.2 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.20 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.87 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
C$31.08 B-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA